Significant tumor inhibition and bone destruction alleviation were observed in the MNNG/HOS nude mouse model (P < 0.001); induced NCL-MDM2–dependent ubiquitination and degradation of c-MET in vitro. (Type A). Here, NUCLEOLIN is linked to neoplasm.